We therefore postulated that deacetylation of C/EBPβ in A549 cells may successfully ameliorate TGF-β1-induced EMT via decrease in α-SMA expression, followed by reduction in excess collagen-I accumulation, a characteristic of lung fibrosis. The gene discussed is CEBPB; the disease is pulmonary fibrosis.